|
HY-103454-5mg
|
MedChemexpress LLC
|
MPP (dihydrochloride) [CAS 911295-24-4]
|
|
Cancer-Kinase/protease
|
|
|
HY-103454B-10mg
|
MedChemexpress LLC
|
MPP (hydrochloride) [CAS 2863676-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-103454B-100mg
|
MedChemexpress LLC
|
MPP (hydrochloride) [CAS 2863676-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-103454B-25mg
|
MedChemexpress LLC
|
MPP (hydrochloride) [CAS 2863676-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-103454B-5mg
|
MedChemexpress LLC
|
MPP (hydrochloride) [CAS 2863676-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-103454B-50mg
|
MedChemexpress LLC
|
MPP (hydrochloride) [CAS 2863676-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P3304-10mg
|
MedChemexpress LLC
|
MR 409 [CAS 1445155-39-4]
|
|
Cancer-programmed cell death
|
|
|
HY-P3304-5mg
|
MedChemexpress LLC
|
MR 409 [CAS 1445155-39-4]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-10mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-100mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-25mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-5mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-50mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-108649A-1mg
|
MedChemexpress LLC
|
MRS2768 (tetrasodium salt) [CAS 2567869-47-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-134813-1mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-10mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-5mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-1mL
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8] (10mM in DMSO)
|
|
|
|
|
HY-139611-1mg
|
MedChemexpress LLC
|
MRTX-1719 [CAS 2630904-45-7]
|
|
Cancer-programmed cell death
|
|
|
HY-139611-10mg
|
MedChemexpress LLC
|
MRTX-1719 [CAS 2630904-45-7]
|
|
Cancer-programmed cell death
|
|
|
HY-139611-25mg
|
MedChemexpress LLC
|
MRTX-1719 [CAS 2630904-45-7]
|
|
Cancer-programmed cell death
|
|
|
HY-139611-5mg
|
MedChemexpress LLC
|
MRTX-1719 [CAS 2630904-45-7]
|
|
Cancer-programmed cell death
|
|
|
HY-18353-10mg
|
MedChemexpress LLC
|
mTOR inhibitor-3 [CAS 1207358-59-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-18353-100mg
|
MedChemexpress LLC
|
mTOR inhibitor-3 [CAS 1207358-59-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-18353-5mg
|
MedChemexpress LLC
|
mTOR inhibitor-3 [CAS 1207358-59-5]
|
|
Cancer-Kinase/protease
|
|
